Maximizing Market Access Success in Switzerland & Croatia. Strategic Dossier Submission and P&R Negotiation.
Secure premium access in Switzerland and unlock strategic CEE insights through your single, dedicated partner.
Access
Strategy
Submission
Insight
Swiss Market Access Strategy
Switzerland is a premium launch market, characterized by high launch prices and a regulated, yet semi-confidential, P&R negotiation environment. Success requires mastering specific mechanisms like indication-based pricing, navigating temporary access (Art. 71), and strategically utilizing data from the mandated registries for products in oncology and rare diseases.
How we can help
- End-to-end dossier preparation for local submission.
- SL (Spezialitätenliste) and Art. 71 submission expertise.
- Pricing & Reimbursement (P&R) negotiation strategies tailored for Swiss authorities.
- ATMP and Rare Disease pathway specialization.
Croatian Market Access Strategy
Croatia serves as a strategic gateway to the CEE region, making it critical for setting regional precedents. Access is heavily focused on Budget Impact (BI) analysis, and pricing is severely constrained by International Reference Pricing (IRP). Mastering the local HZZO list inclusion process and tender strategy is essential to securing and optimizing your presence across Eastern Europe.
How we can help
- Deep local knowledge of Croatian regulatory and reimbursement bodies.
- Rapid dossier submission and lifecycle maintenance.
- HZZO list inclusion and specific tender strategy.
- Bridging Access & Regulatory Pathways for faster patient access.
Strategic Planning & Value Assessment
1.
Strategic Planning
- Pre-Launch Strategy & Optimal Phasing
- Landscape and Competitor Analysis
2.
Pricing & Finance
- Value-Based Pricing Strategy
- Investor Due Dilligence (Risk & Opportunity Assessment)
- Supported by Desk Research and Direct Payer Interviews
Our Partners Trust Our Approach
